on Catheter Precision, Inc.
Catheter Precision Announces First LockeT Order from University of Tennessee
Catheter Precision, Inc., a medical device company based in the U.S., revealed that it has received its first purchase order for the LockeT device in the southeast region. This order comes from the University of Tennessee Medical Center, a prominent facility known for being a referral center and home to the region's only dedicated Heart Hospital.
Marie-Claude Jacques, the Chief Commercial Officer, expressed satisfaction in receiving an order from such a respected institution, setting a promising tone for 2025. The company is preparing for a national launch of LockeT following the expansion of its U.S. sales and clinical teams.
LockeT is a suture retention device designed to aid in hemostasis after venous punctures. The device is FDA-registered as a Class 1 medical device. This development signals successful growth in new U.S. territories, affirming the company's sales strategy.
R. P.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all Catheter Precision, Inc. news